Cargando…
A Bright Horizon: Immunotherapy for Pediatric T-Cell Malignancies
Immunotherapy has transformed the treatment of hematologic malignancies in the past two decades. The treatment of acute lymphoblastic leukemia (ALL), in particular, has been highly impacted by multiple novel immunotherapies. For pediatric patients with T-cell malignancies, translating immunotherapie...
Autores principales: | Newman, Haley, Teachey, David T. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9369002/ https://www.ncbi.nlm.nih.gov/pubmed/35955734 http://dx.doi.org/10.3390/ijms23158600 |
Ejemplares similares
-
Higgs Lectures: Scientific American/Bright Horizons 16
por: Varela, Joao
Publicado: (2013) -
Molecular Research in Penile Cancer—Lessons Learned from the Past and Bright Horizons of the Future?
por: Protzel, Chris, et al.
Publicado: (2013) -
Radiotherapy: Brightness and darkness in the era of immunotherapy
por: Zhai, Danyi, et al.
Publicado: (2022) -
Immunotherapy in endometrial cancer: new scenarios on the horizon
por: Di Tucci, Chiara, et al.
Publicado: (2019) -
Oral Immunotherapy for Food Allergy: Towards a New Horizon
por: Khoriaty, Evelyne, et al.
Publicado: (2013)